Table 4.
Reference | Study population | Biological source | Sequencing technique | Enriched in PSC | Depleted in PSC |
---|---|---|---|---|---|
Tyc et al., 2020 [121] | 5 PSC; 6 cholestatic controls without cholangitis*; 5 cholangitis patients* | Ductal bile | 16S, V3–V4 | Phylum: Proteobacteria | Phylum: Actinobacteria, Bacteroidetes, Firmicutes, and Fusobacteria |
Liwinski et al., 2020 [124] | 43 PSC, 22 cholestatic controls* | Ductal bile | 16S, V1–V2 |
Phylum: Proteobacteria Genus level: Enterococcus, Staphylococcus, Neisseria, Enhydrobacter, Prevotella, Lawsonella, Sphingomonas, Cutibacterium Species level: Enterococcus faecalis, Staphylococcus epidermidis, Streptococcus sanguinis, Enhydrobacter aerosaccus, Prevotella pallens, Veillonella dispar |
Genus level: Collinsella, Clostridium Species level: Gemella sanguinis, Streprococcus gordonii |
Pereira et al., 2017 [123] | 80 PSC (37 with early disease, 32 with advanced disease, and 11 with biliary dysplasia); 46 cholestatic controls* | Ductal bile | 16S, V1–V3 |
Early-stage PSC vs controls: an unclassified Clostridiales, Otu00188, unclassified Neisseriaceae Otu00213) and one family, Staphylococcaceae Early stage PS.C vs advanced stage: genus Streptococcus and several Streptococcus OTUs |
PSC with biliary dysplasia vs other: Prevotella OTU |
PSC, primary sclerosing cholangitis.